ArticleBone marrow transplantation2018

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.

Jennifer Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.